A diethyltartrate-based synthesis of both (-)- and (+)-arundic acid

Tetrahedron Letters

Volumn 50, Issue 43, 2009, Pages 5903-5905

  Fernandes, Rodney A ^a   Dhall, Abhinav ^a   Ingle, Arun B ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

Acute ischemic stroke therapeutic agent; Arundic acid; Diethyltartrate; Johnson Claisen rearrangement

Indexed keywords

ARUNDIC ACID; TARTARIC ACID DERIVATIVE;

ACUTE DISEASE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL REACTION; CHIRALITY; CLAISEN REARRANGEMENT; DIASTEREOISOMER; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; PROTON NUCLEAR MAGNETIC RESONANCE; STROKE;

EID: 69749084183     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2009.08.004     Document Type: Article

References (26)

1. (R)-(-)-Arundic acid or (R)-(-)-2-propyloctanoic acid was discovered by Minase Research Institute of Ono Pharmaceutical Co. Ltd., Osaka, Japan during a screening process and was given the name Ono-2506. See:. Tateishi N., Mori T., Kagamiishi Y., Satoh S., Katsube N., Morikawa E., Morimoto T., Matsui T., and Asano T. J. Cereb. Blood Flow Metab. 22 (2002) 723
2. Sorbera L.A., Castaner J., and Castaner J.M. Drugs Future (2004) 441
3. Kishimoto, K.; Nakai, H. Japan Patent 7-98328, 1995; Chem Abstr. 1997, 126, 74487.
4. Kishimoto, K.; Nakai, H. Japan Patent 7-102693, 1995; Chem Abstr. 1997, 126, 74488.
5. Hasegawa T., and Yamamoto H. Bull. Chem. Soc. Jpn. 73 (2000) 423
6. Hasegawa T., Kawanaka Y., Kasamatsu E., Iguchi Y., Yonekawa Y., Okamoto M., Ohta C., Hashimoto S., and Ohuchida S. Org. Process. Res. Dev. 7 (2003) 168
7. Hasegawa T., and Yamamoto H. Synthesis (2003) 1181
8. Pelotier B., Holmes T., and Piva O. Tetrahedron: Asymmetry 16 (2005) 1513
9. Hasegawa T., Kawanaka Y., Kasamatsu E., Ohta C., Nakabayashi K., Okamoto M., Hamano M., Takahashi K., Ohuchida S., and Hamada Y. Org. Process. Res. Dev. 9 (2005) 774
10. Goswami D., and Chattopadhyay A. Lett. Org. Chem. 12 (2006) 922
11. Garcia J.M., Odriozola J.M., Lecumberri A., Razkin J., and Gonzalez A. Tetrahedron 64 (2008) 10664
12. Fernandes R.A. Eur. J. Org. Chem. (2007) 5064
13. Fernandes R.A. Tetrahedron: Asymmetry 19 (2008) 15
14. Fernandes R.A., and Chavan V.P. Tetrahedron Lett. 49 (2008) 3899
15. Fernandes R.A., Chavan V.P., and Ingle A.B. Tetrahedron Lett. 49 (2008) 6341
16. Fernandes R.A., and Ingle A.B. Tetrahedron Lett. 50 (2009) 1122
17. For Johnson-Claisen rearrangement see:. Johnson W.S., Werthemann L., Bartlett W.R., Brocksom T.J., Li T.-T., Faulkner D.J., and Peterson M.R. J. Am. Chem. Soc. 92 (1970) 741
18. Hiyama T., Kobayashi K., and Fujita M. Tetrahedron Lett. 25 (1984) 4959
19. Ziegler F. Chem. Rev. 88 (1988) 1423
20. Agami C., Couty F., and Evano G. Tetrahedron Lett. 41 (2000) 8301
21. Brenna E., Fuganti C., Gatti F.G., Passoni M., and Serra S. Tetrahedron: Asymmetry 14 (2003) 2401
22. Chan K.-K., Cohen N., De Noble J.P., Specian Jr. A.C., and Saucy G. J. Org. Chem. 41 (1976) 3497
23. 1H NMR.
24. The relative configuration for the C-4 centre in 2a and 2b was assigned after converting them separately into the known enantiomers of arundic acid and working backward. In flash column chromatography the compound 2b was eluted first followed by 2a (petroleum ether/EtOAc, 95:5).
25. 3: 358.2509, found 358.2511.
26. 7,9 The sign of optical rotation values reported in Ref. 9 is just reverse for each enantiomer.